CME America Recalls BodyGuard Microset Infusion Administration Sets
CME America is recalling BodyGuard Microset infusion administration sets due to delivery inaccuracy that may cause over-infusion or under-infusion of therapy.
The agency’s classification
FDA (Devices): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class I, which indicates a reasonable probability that use of the product will cause serious adverse health consequences or death, meeting the criteria for a Severe rating.
Plain-English summary
CME America, LLC is recalling BodyGuard Microset infusion administration sets, reference number A120-160XSFK. The recall involves 273,700 units. The product was distributed across all 50 U.S. states, the District of Columbia, Canada, and the United Kingdom.
The recall was initiated because the infusion administration sets may have a delivery inaccuracy exceeding plus or minus 13 percent, with reported ranges from minus 42.8 percent to plus 17.5 percent. The use of the infusion pump system could result in over-infusion or under-infusion of therapy.
Healthcare facilities and consumers who have these specific infusion administration sets should stop using them and contact CME America, LLC for instructions on return or replacement.
The recalled product
- Product
- BodyGuard Microset, REF: A120-160XSFK
- Manufacturer
- CME America, LLC
- Affected units
- 273,700
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry
Distribution
Part of a larger recall action
This product is one of 37 recalled by CME America, LLC under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 37 products in this recall →Related recalls
Same manufacturer · CME America, LLC
See all →- HighCME America T-Syringe Pump Recalled for Motor Wear and Hardware Damage
FDA (Devices) · 2020-12-09
- HighCME America T-Syringe Pump Recalled for Motor Wear and Fluid Damage
FDA (Devices) · 2020-12-09
- HighCME America Recalls Neofeed Syringe Pumps Due to Motor Wear and Cracks
FDA (Devices) · 2020-12-09
- HighCME America T-Syringe Pump T34 Recalled for Motor Wear and Hardware Cracks
FDA (Devices) · 2020-12-09
- SevereCME America Recalls NeoThrive Syringe Pumps Due to Motor Wear
FDA (Devices) · 2020-12-09
Same hazard · delivery inaccuracy
See all →- HighAlung Technologies Recalls Hemolung Respiratory Assist System Infusion Pumps
FDA (Devices) · 2021-02-10
- SevereCME BodyGuard Microset Infusion Sets Recalled for Delivery Inaccuracy
FDA (Devices) · 2020-07-22
- SevereCME America BodyGuard Microset Infusion Sets Recalled for Delivery Inaccuracy
FDA (Devices) · 2020-07-22
- SevereCME BodyGuard Microset Infusion Sets Recalled for Delivery Inaccuracy
FDA (Devices) · 2020-07-22
- SevereCME America Recalls CMExpress Microbore Sets Due to Delivery Inaccuracy
FDA (Devices) · 2020-07-22
Similar recalls
- CriticalCME BodyGuard Microset Infusion Sets Recalled for Fluid Under-Delivery
FDA (Devices) · 2020-03-18
- HighCME America Recalls BodyGuard Microset Infusion Sets Due to Filter Defect
FDA (Devices) · 2020-05-13
- SevereCME America BodyGuard Infusion Pump Systems Recalled for Delivery Inaccuracy
FDA (Devices) · 2020-03-25
- SevereCME America Recalls BodyGuard 323 Infusion Pumps for Over-Delivery Risk
FDA (Devices) · 2015-02-25
- HighMedtronic MiniMed Pro-set Infusion Sets Recalled for Insulin Over-delivery Risk
FDA (Devices) · 2017-11-29
- HighCareFusion Recalls SmartSite Infusion Sets Due to Tubing Separation Risk
FDA (Devices) · 2013-10-02